[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368840-105":59,"doc-detail-368840-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","post-capsule-endoscopy-small-bowel-cancer-ratean-australian-data-linkage-analysis","Post Capsule Endoscopy Small Bowel Cancer Rate—An Australian Data Linkage Analysis","","Small bowel capsule endoscopy (CE) is a key non-invasive test for suspected small bowel pathology, yet diagnostic miss rates for small bowel cancer remain insufficiently studied. This Australian research evaluates the post-capsule endoscopy small bowel cancer 3-year rate (PCSBC-3Y) by assessing cancer risk within 36 months after a cancer-negative CE, using a prospective CE database and population-based state cancer registry data linkage. Root cause analysis is applied to all PCSBC cases to explain missed diagnoses.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/post-capsule-endoscopy-small-bowel-cancer-ratean-australian-data-linkage-analysis/368840/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/post-capsule-endoscopy-small-bowel-cancer-ratean-australian-data-linkage-analysis/368840.png","ImageObject",300,407,{"name":92,"@type":93},"Franzy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the study evaluate after a cancer-negative capsule endoscopy?","Question",{"text":112,"@type":113},"It quantifies the risk of developing small bowel cancer within 36 months, termed the post-capsule endoscopy small bowel cancer 3-year rate (PCSBC-3Y).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were “detected” and “missed” cancers defined?",{"text":117,"@type":113},"Cancers diagnosed or suspected from CE were treated as detected cancers, while cancers diagnosed within 36 months of a negative CE were treated as missed cancers.",{"name":119,"@type":110,"acceptedAnswer":120},"What method was used to analyze missed diagnoses?",{"text":121,"@type":113},"Root cause analysis (RCA) was performed for each PCSBC case to identify plausible reasons for missed diagnoses.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368840,1790497764,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Journal of Gastrointestinal Cancer (2025) 56:190 [https://doi.org/10.1007/s12029-025-01313-w](https://doi.org/10.1007/s12029-025-01313-w)  \nPost Capsule Endoscopy Small Bowel Cancer Rate—An Australian Data Linkage Analysis  \nParis Hoey1,2 · Naeman Goetz1 · Kimberley Ryan1 · Mark Appleyard1 · Florian Grimpen1  \nAccepted: 4 September 2025 © The Author(s) 2025  \nAbstract  \nPurpose Small bowel (SB) capsule endoscopy (CE) is a well-established investigation for suspected SB pathology, but little research has evaluated the diagnostic miss rate of SB cancer. This Australian study sought to assess the risk of developing SB cancer within 36 months of a cancer-negative CE (PCSBC-3Y) using a novel root-cause analysis (RCA) method. Methods Using a prospective CE database and data linkage with a population-based state cancer registry, the PCSBC-3Y rate was evaluated in consecutive patients undergoing CE between 2007 and 2019. SB cancers diagnosed or suspected from CE were defined as ‘detected cancers’, whilst those diagnosed within 36 months of a negative CE were defined as ‘missed cancers’. Descriptive statistics summarised characteristics for all diagnosed SB cancers. All PCSBC-3Y cases were evaluated by RCA. Results A total of 20 patients were diagnosed with SB cancer within 36 months ofCE, comprising of 18 detected cancers and two missed cancers. The overall PCSBC-3Y rate was 10%(95% CI 2.6–28.7%). The two missed cancers included one jejunal gastrointestinal stromal tumour and one duodenal adenocarcinoma. RCA revealed both missed cancers to be unavoidable, asthe SB was normal on two retrospective reviews of the CE video recordings.  \nConclusion This study introduces the concept of measuring the PCSBC-3Y rate and a novel algorithm of RCA. In our quaternary referral CE cohort, the PCSBC-3Y rate was 10% . A subsequent RCA suggested that the two missed cancers were unavoidable.  \nKeywords Small bowel · Capsule endoscopy · Cancer  \nAbbreviations  \nCE  \nSB  \nPCSBC-3Y  \nRCA  \nRBWH  \nCapsule endoscopy  \nSmall bowel  \nPost-capsule endoscopy small bowel cancer 3-year rate  \nRoot cause analysis  \nRoyal Brisbane and Women’s Hospital  \n* Paris Hoey  \n[p.hoey@uq.edu.au](p.hoey@uq.edu.au); [paris.hoey@health.qld.gov.au](paris.hoey@health.qld.gov.au)  \nNaeman Goetz  \n[naeman.goetz@health.qld.gov.au](naeman.goetz@health.qld.gov.au)  \nKimberley Ryan  \n[kimberley.ryan@health.qld.gov.au](kimberley.ryan@health.qld.gov.au)  \nMark Appleyard  \n[mark.appleyard@health.qld.gov.au](mark.appleyard@health.qld.gov.au)  \nFlorian Grimpen  \n[florian.grimpen@health.qld.gov.au](florian.grimpen@health.qld.gov.au)  \n1 Department of Gastroenterology and Hepatology, Royal Brisbane and Women’s Hospital, Herston 4029, Australia  \n2 University of Queensland, Faculty of Medicine, Brisbane, Australia  \nQCR FN CCISBTT IQR CI IDA  \nNET  \nGIST  \nEMR  \nPCCRC-3Y  \nPEUGIC-3Y  \nQueensland Cancer Register False negative  \nCharlson Comorbidity Index Small bowel transit time Interquartile range Confidence interval  \nIron deficiency anaemia Neuroendocrine tumour Gastrointestinal stromal tumour Endoscopic mucosal resection  \nPost-colonoscopy colorectal cancer 3-year rate  \nPost-endoscopy upper gastrointestinal cancer 3-year rate  \nIntroduction  \nSmall bowel (SB) cancer is rare. Its rarity and absence of specific clinical manifestations renders its diagnosis challenging and often delayed [1–5] . At the time of diagnosis, almost half of SB cancers have metastasised [1] . Most cases  \nare unexpectedly diagnosed through diagnostic work-up of obscure or overt gastrointestinal bleeding that is due to ulceration of the tumour [2, 5] .  \nSince its introduction into clinical practice in the early 2000s, SB capsule endoscopy (CE) has become an invaluable non-invasive diagnostic investigation for SB disease. It does not only have an excellent safety profile, but its potential to visualise the entire SB mucosa results in its high diagnostic yield [4 , 6] . The diagnostic superiority of CE over conventio","cbCaikn94StJpFio","https://ap.wps.com/l/cbCaikn94StJpFio","pdf",975885,"English","# Abstract\n# Introduction\n# Methods\n## Study Site\n## Study Cohort","[{\"question\":\"What does the study evaluate after a cancer-negative capsule endoscopy?\",\"answer\":\"It quantifies the risk of developing small bowel cancer within 36 months, termed the post-capsule endoscopy small bowel cancer 3-year rate (PCSBC-3Y).\"},{\"question\":\"How were “detected” and “missed” cancers defined?\",\"answer\":\"Cancers diagnosed or suspected from CE were treated as detected cancers, while cancers diagnosed within 36 months of a negative CE were treated as missed cancers.\"},{\"question\":\"What method was used to analyze missed diagnoses?\",\"answer\":\"Root cause analysis (RCA) was performed for each PCSBC case to identify plausible reasons for missed diagnoses.\"}]","Post Capsule Endoscopy Small Bowel Cancer Rate—An Australian Data Linkage Analysis | PDF",1790178896,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4fae809927ed134822f8560e55b9cfc6.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/baee755ab4f8b9cc19457b9681a5bd11.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/22ff01fbf7f458a76afabc5e7ff787c9.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d04040f3a449c8c593556d3004ec584.webp",980,1301]